Ipca Laboratories Ltd. (IPCALAB) Share Price Rises 4.76% Today

Ipca Laboratories Ltd. Share Price rises 4.76% to Rs 1,762.4 with a market cap of Rs 43,719.58 Cr. Explore price action, technicals, and fundamentals.

Ipca Laboratories Ltd. Share Price has experienced a notable rise today, increasing by 4.76% to reach Rs 1,762.4. This movement comes as the company, with a market capitalisation of Rs 43,719.58 crore, continues to capture investor attention. The share price opened at Rs 1,698.85 and reached a high of Rs 1,763, reflecting strong buying interest throughout the trading session. This significant price rise places Ipca Laboratories Ltd. among the top gainers in the market today.

< 76%. This achievement highlights the stock's strong performance and positions it as a key player in the healthcare sector. While the data confirms the price event, it does not establish a company-specific catalyst for this movement. Investors and analysts will be closely monitoring the stock's performance in the coming days to assess any further developments.

Ipca Laboratories Ltd. (IPCALAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,762.4
Previous Close	Rs 1,682.25
Today's Change	+Rs 80.15 (+4.76%)
Day Open	Rs 1,698.85
Day High	Rs 1,763
Day Low	Rs 1,682.5
Current Volume (BSE)	10,123
BSE Traded Volume	10,123
NSE Traded Volume	2,12,714
Combined NSE + BSE Volume	2,22,837
Turnover	Rs 1.78 crore
Market Capitalisation	Rs 43,719.58 crore
Market Cap Category	Large Cap

Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,762.4. versus the previous close of Rs 1,682.25, a rise of 4.76%. The stock opened at Rs 1,698.85, reached Rs 1,763, touched Rs 1,682.5. Reported volume was 10,123.

Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 43,719.58 crore

Ipca Laboratories Ltd. operates within the healthcare sector, with a market capitalisation of Rs 43,719.58 crore. The company's valuation metrics, such as the price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, and return on equity (ROE), provide valuable insights into its financial health and performance.

Ipca Laboratories Ltd.'s market capitalisation places it significantly above the sector median of Rs 136.63 crore, highlighting its position as a major player in the industry. The company's financial performance, as reflected in its ROE and return on capital employed (ROCE), will be crucial in assessing its ability to generate returns for shareholders. Investors will be keen to monitor these metrics to gauge the company's long-term growth potential and profitability.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.29x
Benchmark Average P/E	91.55x
Benchmark P/E Range	3.39x to 3,385.56x
Benchmark Median P/B	1.9x
Benchmark Median ROE	10.77%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 43,719.58 crore
Benchmark Median Market Cap	Rs 136.63 crore

Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The healthcare sector, with 198 companies, presents a diverse landscape for investors. Ipca Laboratories Ltd. operates within this sector, which is characterised by a wide range of valuations and performance metrics. The sector's P/E median is 26.29, with an average of 91.55, indicating significant variability in earnings multiples. The P/B median is 1.9, with an average of 2.57, reflecting differing asset valuations among companies.

Ipca Laboratories Ltd.'s market capitalisation of Rs 43,719.58 crore positions it well above the sector median of Rs 136.63 crore, underscoring its prominence in the industry. The company's performance metrics, such as ROE and ROCE, will be critical in evaluating its competitive position and ability to generate shareholder value. As the healthcare sector continues to evolve, investors will be closely monitoring industry trends and company-specific developments to identify potential opportunities and risks.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,945.17	30.21	0.44	-2.89	-0.26
Hikal Ltd.	HIKAL	2,835.92	0	2.35	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,652.68	39.86	8.11	28.21	26.35
Beta Drugs Ltd.	BETA	2,608.51	63.2	10	18.65	22.17
Panacea Biotec Ltd.	PANACEABIO	2,589.99	0	3.07	0	5.36

Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 43,719.58 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Dishman Carbogen Amcis Ltd. has a P/E of 30.21 and a P/B of 0.44, while Kwality Pharmaceuticals Ltd. has a P/E of 39.86 and a P/B of 8.11. These figures highlight the varying valuation multiples within the sector. Ipca Laboratories Ltd.'s market capitalisation of Rs 43,719.58 crore places it significantly above its peers, indicating its strong market position and potential for growth.

Why Investors Are Watching Ipca Laboratories Ltd.

Investors are closely monitoring Ipca Laboratories Ltd. due to its recent share price rise and strong market position. The company's performance in the healthcare sector, coupled with its significant market capitalisation, makes it a key player in the industry.

• Price Action: Share price rose 4.76% today, reaching Rs 1,762.4.
• Technical Position: Increased trading volume indicates strong investor interest.
• Fundamental Context: Market capitalisation of Rs 43,719.58 crore positions it above sector median.
• Sector Positioning: Prominent player in the healthcare sector with diverse valuation metrics.

As the stock continues to gain momentum, investors will be keen to monitor its performance and any potential developments that could impact its valuation and growth prospects.

About Ipca Laboratories Ltd.

Ipca Laboratories Ltd. is a prominent player in the healthcare sector, operating within the pharmaceuticals and drugs industry. The company is known for its diverse range of products and services, catering to various healthcare needs. With a strong market presence and a significant market capitalisation of Rs 43,719.58 crore, Ipca Laboratories Ltd. is well-positioned to capitalise on industry trends and opportunities.

The company's operations span multiple segments, including the manufacturing and distribution of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. Ipca Laboratories Ltd. is committed to delivering high-quality healthcare solutions and maintaining its competitive edge in the market. As the healthcare industry continues to evolve, the company remains focused on innovation and growth to meet the changing needs of its customers and stakeholders.

Track Ipca Laboratories Ltd. Share Price on Univest

Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and market enthusiasts can track Ipca Laboratories Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share prices, technical indicators, fundamental ratios, and shareholding patterns. Users can also explore 52-week levels and gain valuable market insights to make informed investment decisions. Stay updated with the latest developments and trends in the healthcare sector by following Ipca Laboratories Ltd. on Univest.

Frequently Asked Questions

What is the current share price of Ipca Laboratories Ltd.?

Ans. The current share price of Ipca Laboratories Ltd. is Rs 1,762.4, reflecting a 4.76% increase from the previous close of Rs 1,682.25. The stock moved 4.76% during the session. The intraday range extended from Rs 1,682.5 to Rs 1,763.

How much did Ipca Laboratories Ltd. share price rise today?

Ans. Ipca Laboratories Ltd. share price rose by 4.76% today, marking a significant gain in the stock's value. The stock moved 4.76% during the session. The intraday range extended from Rs 1,682.5 to Rs 1,763.

What is the sector benchmark P/E median for healthcare?

Ans. The sector benchmark P/E median for healthcare is 26.29, providing a comparative context for evaluating company valuations. The relevant peer median P/E is 26.29x. The peer average P/E is 91.55x.

How does Ipca Laboratories Ltd. compare to its peers?

Ans. Ipca Laboratories Ltd. has a market capitalisation significantly above its peers, indicating its strong market position and potential for growth. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.

What is the healthcare sector's P/B median?

Ans. The healthcare sector's P/B median is 1.9, indicating varying levels of asset valuation among companies in the industry. The relevant peer median P/E is 26.29x. The peer average P/E is 91.55x.

What is the significance of Ipca Laboratories Ltd.'s share price rise?

Ans. The share price rise of 4.76% positions Ipca Laboratories Ltd. as a top gainer, reflecting strong market interest and potential positive developments. The stock moved 4.76% during the session. The intraday range extended from Rs 1,682.5 to Rs 1,763.

How can investors track Ipca Laboratories Ltd. share price?

Ans. Investors can track Ipca Laboratories Ltd. share price on Univest for real-time updates, technical indicators, and market insights. The stock moved 4.76% during the session. The intraday range extended from Rs 1,682.5 to Rs 1,763.